Table 1.

Baseline patient and treatment characteristics

		Patients (N = 101)
Age (y/o)	Median 72 (47–88)
	Age ≤ 60	13.9 %
	60 < Age ≤ 70	51.5 %
	Age > 70	34.6 %
Race	White	55.6 %
	Black	26.8 %
	Other	17.6 %
Median prostate volume (cc)	Median: 43 (14.0–170.7) cc
Risk groups (D’Amico’s)	Low	36.3 %
	Intermediate	54.9 %
	High	7.8 %
ADT		8.9 %
Baseline AUA score	Median: 9.5
	Mild (1–7):	41.6 %
	Moderate (8–19):	41.6 %
	Severe (20–35):	16.8 %
Baseline SHIM score	Median: 15
	Severe ED (1–7):	34.2 %
	Moderate ED (8–11):	10.5 %
	Mild-Moderate ED (12–16):	7.9 %
	Mild ED (17–21):	21.1 %
	Normal function (>21):	26.3 %